Johannes Attems
#148,930
Most Influential Person Now
Researcher ORCID ID = 0000-0003-1636-1700
Johannes Attems's AcademicInfluence.com Rankings
Johannes Attemscomputer-science Degrees
Computer Science
#7691
World Rank
#8095
Historical Rank
Machine Learning
#2926
World Rank
#2962
Historical Rank
Artificial Intelligence
#3222
World Rank
#3269
Historical Rank
Database
#4747
World Rank
#4930
Historical Rank
Download Badge
Computer Science
Johannes Attems's Degrees
- PhD Computer Science University of Vienna
- Masters Computer Science University of Vienna
- Bachelors Computer Science University of Vienna
Similar Degrees You Can Earn
Why Is Johannes Attems Influential?
(Suggest an Edit or Addition)Johannes Attems's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Diagnosis and management of dementia with Lewy bodies (2017) (1606)
- Primary age-related tauopathy (PART): a common pathology associated with human aging (2014) (988)
- Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report (2019) (646)
- The overlap between vascular disease and Alzheimer’s disease - lessons from pathology (2014) (476)
- Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy (2015) (340)
- Review: Sporadic cerebral amyloid angiopathy (2011) (300)
- Frontotemporal dementia and its subtypes: a genome-wide association study (2014) (262)
- Neuropathological evaluation of mixed dementia (2007) (253)
- Prevalence of dementia disorders in the oldest-old: an autopsy study (2010) (247)
- Interactions of pathological proteins in neurodegenerative diseases (2017) (245)
- Olfactory bulb involvement in neurodegenerative diseases (2014) (235)
- Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease (2008) (221)
- Olfaction and Aging: A Mini-Review (2015) (211)
- Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms (2005) (204)
- Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study (2018) (204)
- Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment. (2016) (189)
- Vascular dementia: Different forms of vessel disorders contribute to the development of dementia in the elderly brain (2012) (169)
- Phosphorylation of different tau sites during progression of Alzheimer’s disease (2018) (163)
- Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology—a pilot study (2004) (163)
- Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias. (2012) (159)
- Neuropathologically mixed Alzheimer’s and Lewy body disease: burden of pathological protein aggregates differs between clinical phenotypes (2015) (155)
- Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias (2014) (154)
- Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology (2012) (154)
- Parietal white matter lesions in Alzheimer’s disease are associated with cortical neurodegenerative pathology, but not with small vessel disease (2017) (152)
- Dementia with Lewy bodies: an update and outlook (2019) (152)
- Alzheimer’s disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy (2005) (148)
- Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease (2005) (147)
- TDP‐43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing (2017) (144)
- Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies? (2006) (141)
- The Vascular Impairment of Cognition Classification Consensus Study (2017) (140)
- White matter connections of the supplementary motor area in humans (2014) (139)
- The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease (2008) (136)
- Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. (2014) (135)
- Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. (2006) (135)
- Vascular risk factors and neurodegeneration in ageing related dementias: Alzheimer's disease and vascular dementia. (2013) (133)
- Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications (2005) (133)
- Olfactory involvement in aging and Alzheimer's disease: an autopsy study. (2005) (132)
- Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease (2007) (131)
- PART, a distinct tauopathy, different from classical sporadic Alzheimer disease (2015) (131)
- Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia (2016) (117)
- Challenges of multimorbidity of the aging brain: a critical update (2015) (116)
- Oxidation of SQSTM1/p62 mediates the link between redox state and protein homeostasis (2018) (114)
- Nuclear localization and phosphorylation modulate pathological effects of alpha‐synuclein (2018) (112)
- Deposition of amyloid β in the walls of human leptomeningeal arteries in relation to perivascular drainage pathways in cerebral amyloid angiopathy☆ (2016) (111)
- Topographical distribution of cerebral amyloid angiopathy and its effect on cognitive decline are influenced by Alzheimer disease pathology (2007) (110)
- Down-Regulation of Sprouty2 in Non–Small Cell Lung Cancer Contributes to Tumor Malignancy via Extracellular Signal-Regulated Kinase Pathway-Dependent and -Independent Mechanisms (2007) (110)
- Post-mortem assessment in vascular dementia: advances and aspirations (2016) (109)
- The Role of Telomerase Protein TERT in Alzheimer's Disease and in Tau-Related Pathology In Vitro (2015) (107)
- Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study (2002) (107)
- Amyloid β peptide 1–42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology (2004) (105)
- Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB (2017) (102)
- Chitinase enzyme activity in CSF is a powerful biomarker of Alzheimer disease (2012) (101)
- Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture (2021) (99)
- Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: association with cognitive impairment (2014) (97)
- Cortical tau load is associated with white matter hyperintensities (2015) (91)
- Capillary cerebral amyloid angiopathy identifies a distinct APOE ε4-associated subtype of sporadic Alzheimer’s disease (2010) (88)
- Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia. (2018) (81)
- Unexpectedly low prevalence of intracerebral hemorrhages in sporadic cerebral amyloid angiopathy (2008) (78)
- Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains (2017) (78)
- Neurochemical mapping of the human hippocampus reveals perisynaptic matrix around functional synapses in Alzheimer’s disease (2013) (77)
- Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies. (2014) (76)
- SIRT1, miR-132 and miR-212 link human longevity to Alzheimer’s Disease (2018) (71)
- Neuropathological approaches to cerebral aging and neuroplasticity (2013) (71)
- Prevalence and impact of cerebrovascular pathology in Alzheimer's disease and parkinsonism (2006) (70)
- Stage-Specific Changes in Neurogenic and Glial Markers in Alzheimer’s Disease (2015) (69)
- Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies – current issues and future directions (2019) (67)
- The relationship between subcortical tau pathology and Alzheimer's disease. (2012) (66)
- Tau and α-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs (2006) (66)
- Dementia in Parkinson's disease is associated with enhanced mitochondrial complex I deficiency (2016) (65)
- Brain microvascular accumulation and distribution of the NOTCH3 ectodomain and granular osmiophilic material in CADASIL. (2013) (63)
- Her-2/neu-triggered intracellular tyrosine kinase activation: in vivo relevance of ligand-independent activation mechanisms and impact upon the efficacy of trastuzumab-based treatment (2003) (61)
- Cause of death in demented and non-demented elderly inpatients; an autopsy study of 308 cases. (2005) (61)
- The need to unify neuropathological assessments of vascular alterations in the ageing brain Multicentre survey by the BrainNet Europe consortium (2012) (60)
- CD8+ T-cells infiltrate Alzheimer’s disease brains and regulate neuronal- and synapse-related gene expression in APP-PS1 transgenic mice (2020) (60)
- The clinical diagnostic accuracy rate regarding the immediate cause of death in a hospitalized geriatric population: an autopsy study of 1594 patients (2004) (60)
- Biomarkers for early diagnosis of Alzheimer disease: ‘ALZheimer ASsociated gene’– a new blood biomarker? (2008) (56)
- Correlations between cortical and subcortical tau pathology (2012) (56)
- Prevalence and pathology of vascular dementia in the oldest-old. (2010) (55)
- Sporadic cerebral amyloid angiopathy is not a frequent cause of spontaneous brain hemorrhage (2007) (54)
- Her‐2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab‐based therapy in patients with metastatic breast cancer (2006) (54)
- Pyroglutamylated amyloid-β is associated with hyperphosphorylated tau and severity of Alzheimer’s disease (2014) (54)
- Pathology of clinical and preclinical Alzheimer’s disease (2013) (54)
- The renaissance of Ca2+-binding proteins in the nervous system: secretagogin takes center stage. (2012) (53)
- Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations. (2007) (53)
- Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study (2021) (52)
- Is there pure vascular dementia in old age? (2010) (51)
- Hippocampal sclerosis in Alzheimer disease and other dementias (2006) (51)
- Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies (2015) (51)
- Discovery of autism/intellectual disability somatic mutations in Alzheimer's brains: mutated ADNP cytoskeletal impairments and repair as a case study (2019) (51)
- Neuropathological correlates of cerebral multimorbidity. (2013) (51)
- Systems proteomic analysis reveals that clusterin and tissue inhibitor of metalloproteinases 3 increase in leptomeningeal arteries affected by cerebral amyloid angiopathy (2016) (50)
- Expression of TAU in insulin-secreting cells and its interaction with the calcium-binding protein secretagogin. (2010) (50)
- Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer’s disease (2018) (49)
- Capillary CAA and perivascular Aβ-deposition: Two distinct features of Alzheimer's disease pathology (2010) (48)
- Cerebral amyloid angiopathy in Lewy body disease (2008) (47)
- Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations (2016) (47)
- Prevalence and Pathology of Dementia with Lewy Bodies in the Oldest Old: A Comparison with Other Dementing Disorders (2011) (47)
- High prevalence of focal and multi-focal somatic genetic variants in the human brain (2018) (47)
- Genetic compendium of 1511 human brains available through the UK Medical Research Council Brain Banks Network Resource (2017) (44)
- Unfolded protein response is activated in Lewy body dementias (2016) (44)
- Comparative platelet proteome analysis reveals an increase of monoamine oxidase-B protein expression in Alzheimer's disease but not in non-demented Parkinson's disease patients. (2012) (43)
- Clinicians' ability to diagnose dementia with Lewy bodies is not affected by β-amyloid load (2015) (43)
- Tau and alpha-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs. (2007) (42)
- Interplay between age, cerebral small vessel disease, parenchymal amyloid-β, and tau pathology: longitudinal studies in hypertensive stroke-prone rats. (2014) (41)
- Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis (2020) (40)
- Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration (2018) (40)
- Improving the identification of dementia with Lewy bodies in the context of an Alzheimer’s-type dementia (2018) (40)
- Exome sequencing in dementia with Lewy bodies (2016) (39)
- Calcium‐binding protein secretagogin‐expressing neurones in the human hippocampus are largely resistant to neurodegeneration in Alzheimer's disease (2007) (38)
- Neuropathology and general autopsy findings in nondemented aged subjects. (2012) (38)
- Unclassifiable tauopathy associated with an A152T variation in MAPT exon 7. (2011) (37)
- Hypertension drives parenchymal β-amyloid accumulation in the brain parenchyma (2014) (37)
- Cytosolic Trapping of a Mitochondrial Heat Shock Protein Is an Early Pathological Event in Synucleinopathies. (2019) (35)
- Is the time ripe for new diagnostic criteria of cognitive impairment due to cerebrovascular disease? Consensus report of the International Congress on Vascular Dementia working group (2016) (34)
- Proteomic characterization of neuromelanin granules isolated from human substantia nigra by laser-microdissection (2016) (34)
- A platelet protein biochip rapidly detects an Alzheimer’s disease-specific phenotype (2014) (34)
- Multisite Assessment of Aging-Related Tau Astrogliopathy (ARTAG) (2017) (32)
- A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers (2018) (30)
- Doublecortin expression in CD8+ T-cells and microglia at sites of amyloid-β plaques: A potential role in shaping plaque pathology? (2018) (30)
- Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (2017) (29)
- Decreased Levels of VAMP2 and Monomeric Alpha-Synuclein Correlate with Duration of Dementia. (2015) (29)
- Neuronal Loss and Α-Synuclein Pathology in the Superior Colliculus and Its Relationship to Visual Hallucinations in Dementia with Lewy Bodies. (2017) (28)
- Quantitative neuropathological assessment to investigate cerebral multi-morbidity (2014) (28)
- Anatomic Connections of the Subgenual Cingulate Region. (2016) (28)
- The Microtubule-Associated Protein Tau and Its Relevance for Pancreatic Beta Cells (2015) (26)
- Frequency of LATE neuropathologic change across the spectrum of Alzheimer’s disease neuropathology: combined data from 13 community-based or population-based autopsy cohorts (2022) (26)
- Facial Onset Sensory and Motor Neuronopathy: Further Evidence for a TDP-43 Proteinopathy (2015) (26)
- Magnetic resonance imaging of fixed post mortem brains reliably reflects subcortical vascular pathology of frontal, parietal and occipital white matter (2013) (26)
- High‐level ERBB2 gene amplification is associated with a particularly short time‐to‐metastasis, but results in a high rate of complete response once trastuzumab‐based therapy is offered in the metastatic setting (2014) (26)
- Concomitant neurodegenerative pathologies contribute to the transition from mild cognitive impairment to dementia (2021) (26)
- Amyloid β peptide 1–42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology (2004) (26)
- Specific patterns of neuronal loss in the pulvinar nucleus in dementia with lewy bodies (2017) (25)
- Early Selective Vulnerability of the CA2 Hippocampal Subfield in Primary Age-Related Tauopathy. (2020) (25)
- Clusters of secretagogin-expressing neurons in the aged human olfactory tract lack terminal differentiation (2012) (24)
- Regional levels of physiological α-synuclein are directly associated with Lewy body pathology (2017) (23)
- Alzheimer Pathology in the olfactory bulb (2005) (23)
- Extravascular fibrinogen in the white matter of Alzheimer’s disease and normal aged brains: implications for fibrinogen as a biomarker for Alzheimer’s disease (2019) (23)
- Frontal white matter lesions in Alzheimer’s disease are associated with both small vessel disease and AD-associated cortical pathology (2021) (22)
- α-Synuclein phosphorylation at serine 129 occurs after initial protein deposition and inhibits seeded fibril formation and toxicity (2022) (22)
- Immunoreactivity of calcium binding protein secretagogin in the human hippocampus is restricted to pyramidal neurons (2007) (22)
- Degeneration of dopaminergic circuitry influences depressive symptoms in Lewy body disorders (2019) (22)
- Changes to the lateral geniculate nucleus in Alzheimer's disease but not dementia with Lewy bodies (2015) (22)
- Lipids, lysosomes and mitochondria: insights into Lewy body formation from rare monogenic disorders (2021) (21)
- Dynamin1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia (2014) (21)
- Quantitative neuropathology: an update on automated methodologies and implications for large scale cohorts (2017) (19)
- Extended post-mortem delay times should not be viewed as a deterrent to the scientific investigation of human brain tissue: a study from the Brains for Dementia Research Network Neuropathology Study Group, UK (2016) (19)
- Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodies (2018) (18)
- Amyloid and tau: neither chicken nor egg but two partners in crime! (2013) (18)
- Reduced secretagogin expression in the hippocampus of P301L tau transgenic mice (2011) (18)
- Frequency and signature of somatic variants in 1461 human brain exomes (2018) (17)
- Pseudomesotheliomatous adenocarcinoma of the lung with rhabdoid features. (2001) (17)
- Increased Transforming Growth Factor β2 in the Neocortex of Alzheimer's Disease and Dementia with Lewy Bodies is Correlated with Disease Severity and Soluble Aβ42 Load. (2017) (17)
- Microglia depletion diminishes key elements of the leukotriene pathway in the brain of Alzheimer’s Disease mice (2020) (16)
- The Pattern of AQP4 Expression in the Ageing Human Brain and in Cerebral Amyloid Angiopathy (2020) (16)
- An isoform‐specific role of FynT tyrosine kinase in Alzheimer's disease (2016) (16)
- Oligogenic genetic variation of neurodegenerative disease genes in 980 postmortem human brains (2018) (16)
- Amyloid PET and MRI in Alzheimer's disease and mild cognitive impairment. (2009) (16)
- Pathological Changes to the Subcortical Visual System and its Relationship to Visual Hallucinations in Dementia with Lewy Bodies (2019) (15)
- Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body Dementia (2017) (15)
- Ewing’s Sarcoma and Peripheral Primitive Neuroectodermal Tumor in Adults: Different Features of a Rare Neoplasm (2008) (15)
- Importance of Proactive Treatment of Depression in Lewy Body Dementias: The Impact on Hippocampal Neurogenesis and Cognition in a Post-Mortem Study (2018) (14)
- Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates (2020) (13)
- Common Impact of Chronic Kidney Disease and Brain Microhemorrhages on Cerebral Aβ Pathology in SHRSP (2017) (13)
- Concordance between epidermal growth factor receptor status in primary non-small-cell lung cancer and metastases: a post-mortem study. (2010) (13)
- Cholinergic deficits and galaninergic hyperinnervation of the nucleus basalis of Meynert in Alzheimer’s disease and Lewy body disorders (2020) (13)
- The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies (2020) (13)
- Neuropathology and biochemistry of early onset familial Alzheimer’s disease caused by presenilin-1 missense mutation Thr116Asn (2018) (12)
- Protease-resistant SOD1 aggregates in amyotrophic lateral sclerosis demonstrated by paraffin-embedded tissue (PET) blot (2014) (12)
- Alzheimer's disease pathology explains association between dementia with Lewy bodies and APOE-ε4/TOMM40 long poly-T repeat allele variants (2019) (11)
- Comparative anatomical distribution of neuronal calcium-binding protein (NECAB) 1 and -2 in rodent and human spinal cord (2016) (11)
- Investigating the presence of doubly phosphorylated α‐synuclein at tyrosine 125 and serine 129 in idiopathic Lewy body diseases (2020) (11)
- Erratum to: Comparative anatomical distribution of neuronal calcium-binding protein (NECAB) 1 and -2 in rodent and human spinal cord (2016) (11)
- The multi-morbid old brain (2017) (11)
- Lewy body pathology is more prevalent in older individuals with mitochondrial disease than controls (2019) (11)
- A new visual rating scale for Ioflupane imaging in Lewy body disease (2018) (11)
- Genome-wide association study and functional validation implicates JADE1 in tauopathy (2021) (10)
- 123I-FP-CIT SPECT in dementia with Lewy bodies, Parkinson’s disease and Alzheimer’s disease: a new quantitative analysis of autopsy confirmed cases (2021) (10)
- Down-Regulation of Sprouty 2 in Non – Small Cell Lung Cancer Contributes to Tumor Malignancy via Extracellular Signal-Regulated Kinase Pathway-Dependent and-Independent Mechanisms (2007) (10)
- Neuropsychiatric symptoms in limbic-predominant age-related TDP-43 encephalopathy and Alzheimer’s disease (2020) (10)
- Neuropathological Changes in Dementia With Lewy Bodies and the Cingulate Island Sign (2019) (9)
- Concomitant LATE‐NC in Alzheimer's disease is not associated with increased tau or amyloid‐β pathological burden (2020) (9)
- PARIETAL WHITE MATTER LESIONS IN ALZHEIMER’S DISEASE ARE ASSOCIATED WITH CORTICAL NEURODEGENERATIVE PATHOLOGY AND NOT WITH SMALL-VESSEL DISEASE (2017) (9)
- PTEN expression as a predictor for the response to trastuzumab-based therapy in Her-2 overexpressing metastatic breast cancer (2017) (9)
- Alzheimer's disease pathology in synucleinopathies (2017) (9)
- Correlation of pyroglutamate amyloid β and ptau Ser202/Thr205 levels in Alzheimer’s disease and related murine models (2020) (9)
- Dynamin 1 concentration in the prefrontal cortex is associated with cognitive impairment in Lewy body dementia (2015) (8)
- Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies (2022) (8)
- Gene Expression Imputation Across Multiple Tissue Types Provides Insight Into the Genetic Architecture of Frontotemporal Dementia and Its Clinical Subtypes (2021) (8)
- The efficacy of trastuzumab in Her-2/neu-overexpressing metastatic breast cancer is independent of p53 status (2005) (8)
- Reply: LATE to the PART-y. (2019) (8)
- Neurodegenerative Diseases and Ageing. (2019) (8)
- Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s (2022) (7)
- Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into the complex genetic architecture (2020) (7)
- Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies (2020) (7)
- RAB39B is redistributed in dementia with Lewy bodies and is sequestered within aβ plaques and Lewy bodies (2020) (7)
- Cerebral amyloid angiopathy distribution in older people: A cautionary note (2021) (7)
- Interpretable deep learning of myelin histopathology in age-related cognitive impairment (2022) (6)
- Erratum: Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy in post-mortem brain tissue. (2015) (6)
- Erratum to: Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains (2017) (6)
- Lung disease 35 years after aspiration of activated charcoal in combination with pulmonary lymphangioleiomyomatosis (2006) (6)
- Rare histotype of sporadic Creutzfeldt-Jakob disease, clinically suspected as corticobasal degeneration (2019) (6)
- Capillary CAA and perivascular Abeta-deposition (2010) (6)
- Author response: Autopsy validation of 123I-FP-CIT dopaminergic neuroimaging for the diagnosis of DLB (2017) (6)
- Vascular α1A Adrenergic Receptors as a Potential Therapeutic Target for IPAD in Alzheimer’s Disease (2020) (6)
- Interpretable deep learning of myelin histopathology in age-related cognitive impairment (2022) (6)
- Age related changes in pancreatic beta cells: A putative extra-cerebral site of Alzheimer's pathology. (2011) (5)
- Genetic risk for Alzheimer’s disease influences neuropathology via multiple biological pathways (2020) (5)
- Neuropathological and biochemical investigation of Hereditary Ferritinopathy cases with ferritin light chain mutation: Prominent protein aggregation in the absence of major mitochondrial or oxidative stress (2020) (5)
- LATE-NC staging in routine neuropathologic diagnosis: an update (2022) (5)
- Rapidly progressing diffuse Lewy body disease (2011) (4)
- Stage-Speci fi c Changes in Neurogenic and Glial Markers in Alzheimer ’ s Disease (2015) (4)
- Insights into Lewy body disease from rare neurometabolic disorders (2021) (4)
- Cortical tau pathology: a major player in fibre-specific white matter reductions in Alzheimer's disease? (2018) (4)
- Relationship Between Tau, β Amyloid and α-Synuclein Pathologies. (2019) (4)
- Vascular Cognitive Impairment Neuropathology Guidelines (VCING) - a UK multi-centre consensus study (2016) (3)
- Proteomics for synaptic markers of cognitive decline in neurodegenerative diseases. (2018) (3)
- Common Variants Near ZIC1 and ZIC4 in Autopsy‐Confirmed Multiple System Atrophy (2022) (3)
- Mendelian randomization implies no direct causal association between leukocyte telomere length and amyotrophic lateral sclerosis (2020) (3)
- Active Her-2/neu signal transduction in breast cancer -relevance of a ligand-independent activation mechanism and impact on the efficacy of trastuzumab-based treatment. (2004) (3)
- P1-367 Nested gene and autoimmune response in Alzheimer’s disease (2006) (3)
- The semi-quantitative assessment of subcortical small vessel disease pathology in elderly subjects: an initiative from the UK BD collaboration (2011) (2)
- The aetiology of frontal white matter lesions in Alzheimer’s disease are associated with both neurodegenerative and ischemic mechanisms (2020) (2)
- Spreading Pathologies Precede Cognitive Decline in Alzheimer’s Disease (2015) (2)
- Erratum to: Comparative anatomical distribution of neuronal calcium-binding protein (NECAB) 1 and -2 in rodent and human spinal cord (2016) (2)
- Neuropathology of Parkinson's disease dementia and dementia with Lewy bodies (2009) (2)
- Neurodegenerative brain changes are associated with area deprivation in the United Kingdom: findings from the Brains for Dementia Research study (2021) (2)
- Catheter-related Leuconostoc bacteremia secondary to pulmonary Mycobacterium xenopi infection (2007) (2)
- RPT6, 20S α-6 AND α-3 PROTEASOME SUBUNIT LEVELS AND ASSOCIATION WITH COGNITIVE DECLINE IN ALZHEIMER’S DISEASE AND LEWY BODY DEMENTIAS (2017) (2)
- Alpha-synuclein is present in the nucleus in human brain tissue and is pathologically modified in Dementia with Lewy Bodies (2021) (2)
- Author Correction: Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (2018) (2)
- Tangle dominant dementia - comparison with classical Alzheimer disease (2011) (1)
- Quantitative neuropathological assessment to investigate cerebral multi-morbidity (2014) (1)
- Erratum: Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report. (Brain (2019) 142, (1503–1527) DOI: 10.1093/brain/awz099) (2019) (1)
- Prion-like α-synuclein pathology in the brain of infants with Krabbe disease (2022) (1)
- Do senescent cells play a role in Alzheimer’s disease? (2020) (1)
- Magnetic resonance imaging detects subcortical vascular pathology in post mortem brains (2012) (1)
- The impact of vascular and Alzheimer pathologies in Lewy body disease (2009) (1)
- Cerebral Small Vessel Disease: Pathologic aspects of the hemorrhagic consequences of small vessel disease on the brain (2014) (1)
- Pyroglutamylated beta-amyloid is associated with hyperphosphorylated tau in human post-mortem brains (2013) (1)
- Chitinase Enzyme Activity in Cerebral Spinal Fluid is Strongly Associated with Alzheimer’s Disease (2011) (1)
- The impact of concomitant LATE‐NC on hyperphosphorylated tau pathology and cognitive decline in Alzheimer’s disease (2020) (1)
- Reply: Atherosclerosis and vascular cognitive impairment neuropathological guideline. (2017) (1)
- Immune-related genetic enrichment in frontotemporal dementia (2017) (1)
- OLFACTORY NEURODEGENERATIVE PATHOLOGY IN NEURODEGENERATIVE DISEASE (2014) (1)
- Tissue microarray in the quantification of hyper-phosphorylated tau, amyloid-beta and alpha-synuclein (2013) (1)
- Pyroglutamylated Amyloid-beta correlates with Hyperphosphorylated Tau and Severity of Alzheimer's Disease (2014) (1)
- VALIDATION BY NEUROPATHOLOGY OF FP-CIT NEUROIMAGING IN DEMENTIA WITH LEWY BODIES (2017) (1)
- O2-01-04 Tau and alpha-synuclein brainstem pathology in Alzheimer disease (2006) (1)
- High prevalence of focal and multi-focal somatic genetic variants in the human brain (2018) (0)
- Reply to Mordant et al. (2011) (0)
- The phenotype associated with the novel A152T mutation in MAPT exon 7 (2009) (0)
- Brain microvascular accumulation and distribution of GOM and the NOTCH3 ectodomain in CADASIL (2013) (0)
- 122nd Meeting of the British Neuropathological Society (2021) (0)
- Calcium binding protein Secretagogin expression in wild type and transgenic tau (P301L) mice (2009) (0)
- Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (2017) (0)
- RELATIONSHIP BETWEEN PATHOLOGY SCORES, CLINICAL DATA AND EXPRESSION LEVELS OF PROTEASOME SUB-UNITS IN ALZHEIMER’S DISEASE AND LEWY BODY DEMENTIAS (2017) (0)
- Secretagogin is expressed in hippocampal neurones of wild type but not of tau-homocygote (P301L) mice (2008) (0)
- A comparison of cerebral small vessel disease severity between autopsy cohorts in the northeast of England and Sacramento County in California, USA (2020) (0)
- Olfactory pathology in aging and Alzheimer disease (2005) (0)
- Are early stage tau depositions associated with pyroglutamylated Aβ in Alzheimer’s disease? (2020) (0)
- NEUROPATHOLOGY (1936) (0)
- ANALYSIS OF SPATIO-TEMPORAL FEATURES OF HISTOPATHOLOGY IN MURINE ALZHEIMER'S DISEASE MODELS AND HUMAN ALZHEIMER'S DISEASE SAMPLES (2016) (0)
- CAA IN MUTANT AD MICE: A COMPARATIVE STUDY TO HUMAN AD CASES (2014) (0)
- Cerebral Accumulation, Distribution and Clearance of GOM and NOTCH3 fragments in CADASIL (2012) (0)
- Genome-wide association study of autopsy-confirmed Multiple System Atrophy identifies common variants near ZIC1 and ZIC4 (2021) (0)
- Pyroglutamylated amyloid-beta is associated with hyperphosphorylated tau in human post mortem brains (2014) (0)
- Cortical tau load is associated with white matter hyperintensities (2015) (0)
- Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias (2023) (0)
- Nigral pathology in older persons without Parkinson disease (2012) (0)
- IMMUNE CELL INTERACTIONS IN AMYLOID-BETA PLAQUE PATHOLOGY (2017) (0)
- Quantification of small vessel disease in frontal and parietal white matter, genu and splenium (2020) (0)
- [abstract] The abscess formation by Cryptococcus neoformans with underlying Sarcoide and distinct immunodeficiency (2009) (0)
- Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer’s disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity (2020) (0)
- Oxidation of SQSTM1/p62 mediates the link between redox state and protein homeostasis (2018) (0)
- Dementia with Lewy bodies: an update and outlook (2019) (0)
- ErbB2/CEP17 and total ErbB2 copy number as independent forecast factor for time to First Metastasis (TTM) and with a trastuzumab-based therapy in HER2 testing metasase breast cancer [abstract] (2010) (0)
- Different Neprilysin expression in vessels of occipital and frontal lobes (2009) (0)
- [abstract] Tau and alpha-syunclein brainstem lesions in Alzheimer disease (2006) (0)
- Neuropathological diagnostic accuracy of corticobasal degeneration: A review of 140 cases (2015) (0)
- Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations (2016) (0)
- Mechanisms involved in the regulation of Sprouty4 expression (2007) (0)
- P3-416 PROFILE OF INTRACELLULAR CHOLESTEROLTRAFFICKING IN POSTMORTEM BRAINS OF DOWN SYNDROME AND ALZHEIMER DISEASE (2017) (0)
- Correlation between the synaptic zinc transporter znt3 and alpha-synuclein in dementia (2015) (0)
- Aging 6-2019 Limbic-Predominant Age-Related TDP-43 Encephalopathy ( LATE ) : Consensus Working Group Report (2019) (0)
- The first year (2019) (0)
- Neurogenic marker alterations in the hippocampus in relation to cholinergic therapy in Lewy Body dementia (2014) (0)
- Methods for Pathological Classification of Alzheimer’s Disease (2018) (0)
- Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies (2020) (0)
- Nuclear alpha-synuclein is present in the human brain and is modified in dementia with Lewy bodies (2022) (0)
- Protease-resistant SOD1 aggregates in amyotrophic lateral sclerosis demonstrated by paraffin-embedded tissue (PET) blot (2014) (0)
- Phosphorylation of different tau sites during progression of Alzheimer’s disease (2018) (0)
- Impairments to the lateral geniculate nucleus in Alzheimer ’ s disease but not dementia with Lewy bodies (2018) (0)
- CHARACTERIZATION OF VASCULAR ALTERATIONS IN HUMAN ALZHEIMER'S DISEASE PATIENTS IN COMPARISON TO THE APPSL AND 5XFAD MOUSE MODELS (2016) (0)
- Analysis of Primary Visual Cortex in Dementia with Lewy Bodies Indicates Abnormal Inhibitory Neurotransmission and Involvement of Bottom Up Pathways (2018) (0)
- The prevalence of TDP-43 pathology in Alzheimer's disease, Lewy body dementia and mixed Alzheimer's disease and Lewy body disease (2016) (0)
- Cytosolic Trapping of a Mi tochondrial Heat Shock Protein Is an Early Pathological Event in Synucleinopathies Graphical (2019) (0)
- European Journal of Geriatrics (2006) (0)
- Neuropathology of age-associated neurodegenerative diseases (2009) (0)
- Investigating the pathological correlate of motor dysfunction in DLB and PDD (2016) (0)
- THE ROLE OF CORTICAL HYPERPHOSPHORYLATED TAU PATHOLOGY IN THE PATHOGENESIS OF WHITE MATTER LESIONS IN ALZHEIMER'S DISEASE (2014) (0)
- Contribution of Alzheimer's disease and Lewy body pathology to behavior and cognition in Lewy body dementias (2013) (0)
- Prion-like α-synuclein pathology in the brains of infants: Krabbe disease as a novel seed-competent α-synucleinopathy (2021) (0)
- Neuropathology of Parkinson's disease Dementia (PDD) and Dementia with Lewy bodies (DLB) (2008) (0)
- Pathological Changes to the Subcortical Visual System and its Relationship to Visual Hallucinations in Dementia with Lewy Bodies (2019) (0)
- Global proteomic profiling of brain leptomeningeal arteries from patients with cerebral amyloid angiopathy reveals novel therapeutic targets (2015) (0)
- NEUROPATHOLOGY (1924) (0)
- The four repeat tau isoform 5 represents a calcium-dependent interaction partner of secretagogin (SCGN) (2009) (0)
- Contents Vol. 61, 2015 (2015) (0)
- Tau hyperphosphorylation in Alzheimer’s disease: Systematic quantification of common disease-relevant phospho-sites (2015) (0)
- Sporadic cerebral amyloid angiopathy—No frequent cause of spontaneous brain hemorrhage in the aged (2009) (0)
- Neurodegenerative brain changes are associated with area deprivation in the United Kingdom: findings from the Brains for Dementia Research study (2021) (0)
- Improving the identification of dementia with Lewy bodies in the context of an Alzheimer’s-type dementia (2018) (0)
- Genetic risk for Alzheimer’s disease influences neuropathology and cognition via multiple biological pathways (2020) (0)
- Frequency and signature of somatic variants in 1461 human brain exomes (2018) (0)
- Cortical neurodegenerative pathology has an influence on white matter integrity (2014) (0)
- Assessment of the contribution of common genetic variants associated with Alzheimer’s disease on neuropathological burden and clinical characteristics in the Brains for Dementia Research cohort (2020) (0)
- Edinburgh Research Explorer Vascular 1A Adrenergic Receptors as a Potential Therapeutic Target for IPAD in Alzheimer’s Disease (2020) (0)
- Tau Hyperphosphorylation in Human Alzheimer's Disease (AD) Cases: A Quantitative Histological Comparison (2014) (0)
- Cleaved Annexin A1 is elevated in neurodegenerative dementia and is associated with pathological burden of amyloid and inflammatory cytokines (2020) (0)
- Author Correction: Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS (2018) (0)
- 0745 Expression of a piggy-back-gene determines Alzheimer disease pathology? (2005) (0)
- Distribution of Amyloid Peptide Beta 1-40 and 1-42 in Cerebral Amyloid Angiopathy and Correlation with Alzheimer Disease Pathology (2004) (0)
- Decreased JNK3 levels are associated with amyloid plaque and neurofibrillary tangles in dementia patients (2020) (0)
- The pattern of failure of perivascular elimination of Amyloid-beta in Alzheimer's disease (2013) (0)
- Mixed brain pathologies account for most dementia in the UK’s Brains for Dementia Research cohort (2020) (0)
- O1-01-03 Alzheimer disease pathology influences the impact of cerebral amyloid angiopathy on cognitive decline (2006) (0)
- Olfactory involvement in ageing and Alzheimer disease (2005) (0)
- QUANTIFICATION OF PATHOLOGICAL LESIONS DETECTS CLINICOPATHOLOGICAL PHENOTYPES OF MIXED AD/LBD (2014) (0)
- [abstract] A 18-year-old Girl with Fever, Cough, and cystic Lesions in the Lungs (2009) (0)
- Olfactory neurodegenerative pathology in neurodegenerative diseases (2014) (0)
- SIRT1, miR-132 and miR-212 link human longevity to Alzheimer’s Disease (2018) (0)
- Erratum to: Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains (2017) (0)
- Acknowledgement of reviewers 2015–16 (2016) (0)
- In honor of the 80th birthday of Kurt Jellinger: a living legend in neuropathology (2011) (0)
- 126PD EGFR STATUS OF PRIMARY NSCLC REMAINS UNCHANGED IN LYMPH NODE AND ORGAN METASTASES: AN AUTOPSY STUDY (2009) (0)
- Quantification of pathology in mixed Alzheimer's disease and Lewy body dementia (2013) (0)
- A case of facial onset sensory and motor neuronopathy (FOSMN) associated with TDP-43 proteinopathy (2015) (0)
- Connectivity of the Subgenual Cingulate Region (2018) (0)
- Mitochondrial dysfunction is a key pathological driver of early stage Parkinson’s (2022) (0)
- Capillary CAA defines a subtype of Alzheimer's disease while pericapillary A beta is a type of early A beta deposition (2011) (0)
- Calcium binding protein secretagogin and neuroprotection in Alzheimer's disease (2008) (0)
- O2-04-04 Relations between cerebral amyloid angiopathy and Alzheimer's disease pathology (2004) (0)
- Axonal degeneration secondary to cortical neurodegeneration; a potential cause for white matter lesions? (2013) (0)
- Diagnostic approach to Argyrophilic Grain Disease (AGD): an UK BDR trial (2013) (0)
- Use of the ErbB2/CEP17 ratio to predict prognosis and response to trastuzumab-based therapy in the metastatic breast cancer setting. (2009) (0)
- TISSUE MICROARRAY AND QUANTITATIVE NEUROPATHOLOGY: A HIGH THROUGHPUT METHODOLOGY FOR NEUROPATHOLOGICAL ASSESSMENT OF LARGE SCALE COHORTS (2017) (0)
- Supplementary material (Baek et al. 2015) (2015) (0)
- P3-183 Cellular immunoreactivity of calcium-binding protein secretagogin in human hippocampus is restricted to pyramidal neurons (2006) (0)
- Title: Interpretable deep learning of myelin histopathology in age-related cognitive impairment Running Title: Deep learning of histopathology in cognitive impairment (2022) (0)
- Hierarchical pathological progression of corticobasal degeneration (2017) (0)
- Comparative anatomical distribution of neuronal calcium-binding protein (NECAB) 1 and -2 in rodent and human spinal cord (2016) (0)
- Synaptic dysfunction and correlations with clinico-pathological features in dementia with Lewy bodies and Parkinson's disease dementia (2013) (0)
- 123rd meeting of the British Neuropathological Society (2022) (0)
- Cortical hyperphosphorylated tau load is a predictor for white matter lesions in Alzheimer’s disease (2015) (0)
- Cellular vulnerability in Lewy body diseases (2020) (0)
- CD8+ T-cell-mediated contribution to neuropathology in a transgenic Alzheimer’s disease mouse model (2019) (0)
- New aspects of membrane breakdown in Alzheimer's disease brain (2009) (0)
- Mitochondrial DNA point mutations and relative copy number in 1363 disease and control human brains (2017) (0)
- First Scientific Session (2013) (0)
- Microglia depletion diminishes key elements of the leukotriene pathway in the brain of Alzheimer’s Disease mice (2020) (0)
- Correlation of Aβ‐pE(3) and ptau in human and mouse brain (2020) (0)
- Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia (2018) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Johannes Attems?
Johannes Attems is affiliated with the following schools:
